scholarly journals MEMBANGUN KESADARAN DAN PERILAKU HIDUP SEHAT MAHASISWI GUNA MENCEGAH KANKER PAYUDARA

2021 ◽  
Vol 2 (2) ◽  
pp. 107
Author(s):  
Ni Luh Nyoman Kebayantini ◽  
I Nengah Punia ◽  
Nazrina Zuryani ◽  
Wahyu Budi Nugroho ◽  
Gede Kamajaya ◽  
...  

Breast cancer is the second highest prevalence after cervical cancer. In recent years cases of breast tumors that are at risk of becoming cancer are found in women aged 25 years and under. This risk will increase in adolescent girls who have a history of tumors, so there is a 4.37 times more risk of developing breast cancer. Similarly, young women who experience menarche (first menstruation) at the age of <12 years are more likely to develop breast cancer than those who experience menarche aged> 12 years. Busyness undergoing daily routine is also one of the causes of teenagers / young women paying less attention to the health of their breasts. Based on this there have been many campaigns and movements to foster women's awareness of breast cancer such as the BSE movement (Breast Self-Check) and SADANIS (aware of clinical examination). It is unfortunate that this campaign has not been able to touch all circles, especially among students who are very busy with campus life and do not have the awareness to take care of their health. This dedication activity is carried out to increase the awareness of students / young women to maintain breast health. Keywords: breast cancer, health, increase student awareness.

2010 ◽  
Vol 63 (9-10) ◽  
pp. 657-661 ◽  
Author(s):  
Milena Veljkovic ◽  
Slavimir Veljkovic

Introduction. Oral contraceptives, mainly combined monophasic pills, are widely used by young women who expect their physicians to prescribe them safe drugs which will not harm their health and which will simplify their life. Numerous epidemiologic studies have been performed to determine the relation between oral contraceptive use and the development of neoplasms. Breast cancer. An increased incidence of breast cancer has occurred simultaneously with the growing use of oral contraceptives. The possibility of a link between the oral contraceptive use and breast cancer has led to intensive research, but studies have provided inconsistent results causing confusion among clinicians. It was noticed that the risk of breast cancer was slightly elevated in current and recent young oral contraceptives users. That finding could be influenced by a detection bias or could be due to the biologic effect of the pills. The absolute number of additional breast cancer cases will be very small because of low baseline incidence of the disease in young women. Oral contraceptives probably promote growth of the already existing cancer, they are probably promoters not initiators of breast cancer. The available data do not provide a conclusive answer that is need. Cervical cancer. Numerous factors may influence the development of cervical cancer. The evidence suggests that current and recent oral contraceptive users have an increased risk of cervical cancer which decline after discontinuation of the application of medication. Oral contraceptives might increase the biological vulnerability of the cervix. Cervical cancer develops slowly over a long time period and can be effectively prevented by periodic cervical screening. Fortunately, oral contraceptives do not mask abnormal cervical citology. Conclusions regarding invasive cervical cancer and oral contraceptive use are not definitive but if there is any increased risk, it is low. Endometrial cancer. In oral contraceptive users the endometrium is almost under the influence of progestin component which suppresses endometrial mitotic activity and its proliferation. Most epidemiologic studies show that oral contraceptives reduce the risk of endometrial cancer and that this protective effect exists many years after the discontinuation of medication. Ovarian cancer. It has been long known that the oral contraceptive use causes protective an ovulation and reduces the risk of ovarian cancer. This powerful reduction is the best demonstrated major benefit of oral contraception. This protection is especially observed in nulliparous and seems to persist for many years after the discontinuation of medication.


2017 ◽  
Vol 66 (1) ◽  
pp. 24-33 ◽  
Author(s):  
Nancy Angeline Gnanaselvam ◽  
Bobby Joseph

Stress and depression are common in textile industry employees due to inadequate working conditions and challenging socioeconomic conditions. The objective of the study was to assess depression and mental health among adolescent and young females currently employed in a textile factory located in Tamil Nadu compared with past employees and women who have never been employed. This cross-sectional study included a total of 107 participants in each study group who were interviewed. The Patient Health Questionnaire–9 and Strengths and Difficulties Questionnaire were administered to screen participants for depression and mental health. More current employees (16.82%) and past employees (15.88%) suffered from depression severe enough to require treatment compared with never employed girls and young women (2.8%). Of the study participants, 59.8% of current employees, 63.6% of past employees, and 32.7% of never employed women had mental health or behavior problems. In the regression model, history of abuse was significantly associated with depression. Participants who were current employees and reported family debt and a history of abuse were significantly more likely to have mental health or behavior problems. Mental health issues such as depression and behavior problems were more likely among adolescent girls currently employed in textile industries. Further studies into the causes of this phenomenon are needed.


2021 ◽  
Author(s):  
Sadaf Alipour ◽  
Hadi Rashidi ◽  
Khadije Maajani ◽  
Marzieh Orouji ◽  
Yas Eskandari

Abstract Background Health status and perception can be assessed by general or disease-specific questionnaires, the latter are more sensitive. Considering the importance of breast health in women’s lives and the lack of any pertinent questionnaire, we performed this study to develop a valid and reliable short BH questionnaire (BHQ); and then use it for the assessment of participants. Methods We first designed and developed the instrument, followed by measurement of inter-rater agreement IRA, content validity including content validity index (I-CVI) and scale content validity index (S-CVI), and reliability (through internal consistency and test-retest). We then included eligible women with normal breasts and benign breast disorders who attended our breast clinic. Results The IRA index (78.6%) showed optimal relevance and clarity of the questionnaire. The content validity was acceptable; with an S-CVI of 87.35 and 84.42 for clarity and relevance, respectively. One question was eliminated (I-CVI < 70%). The internal reliability was high (Cronbach’s alpha = 0.93). For external consistency, three questions were eliminated (intraclass correlation coefficient < 0.7), the rest of the questions showed good and excellent reliability. In the next step, BH in the 350 eligible participants showed an overall score of 55.86 ± 11.57. Among different variables, age was the only one that showed a significant direct relationship with BH. A history of breast surgery for benign lesions and a family history of breast cancer did not affect BH. Conclusion This study introduces a valid reliable 11-item BHQ. We propose its use in various conditions throughout breast cancer screening, diagnosis, and treatment; and in the assessment of BH in various physiologic and reproductive situations.


2018 ◽  
Vol 4 (Supplement 3) ◽  
pp. 7s-7s
Author(s):  
Anna Cabanes ◽  
Mary Rose Giattas ◽  
Mavalynne Orozco-Urdaneta ◽  
Groesbeck Parham ◽  
Leeya Pinder ◽  
...  

Purpose Cancer is becoming an urgent problem in low- and middle-income countries as the global burden of disease shifts from infectious to noncommunicable diseases. Whereas cervical cancer and breast cancer are preventable and treatable, these diseases are the leading causes of women’s cancer deaths in low-resource settings, mostly because of late-stage presentation and limited diagnostic and treatment capacities. Methods Using the Breast Health Global Initiative resource-stratified guidelines and a phased implementation approach, countries with resource constraints have designed and implemented breast cancer interventions that allow for a balanced, efficient, and equitable use of limited resources. Results Tanzania, Zambia, and a rural area of Colombia serve as examples of evidence-based approaches to the implementation of breast cancer control programs, leveraging the successes and experiences of existing care platforms—mostly cervical cancer and HIV—while creating a solid foundation for country ownership and sustainability. Tanzania used a top-down approach, investing in understanding the needs through a breast health care assessment to inform policy and practice, as well as building a national policy framework. Zambia analyzed the successes and experiences of their public Cervical Cancer Prevention Program to introduce breast cancer education, detection, and surgical treatment, and to improve the time of diagnosis for breast cancer using the single-visit approach recommended by WHO for cervical cancer. A rural community in Colombia has focused on mitigating some of the most common barriers that women face during their cancer journey by improving the cancer education of medical personnel, providing technology for early diagnosis, and implementing an outreach and navigation program that has significantly reduced waiting times from screening through diagnosis and treatment. Conclusion What are key characteristics that guarantee success? Country ownership is crucial, with political, institutional, and community ownership; capabilities; and accountability. Under these four dimensions and a phased implementation framework, we explain the approach that civil society, ministries of health, and stakeholders have taken to implement these programs. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc . Anna Cabanes Research Funding: Pfizer, Genentech, Merk (Inst) Travel, Accommodations, Expenses: Pfizer, Astra Zeneca Mary Rose Giattas Research Funding: Pfizer, Genentech, Merk (Inst) Travel, Accommodations, Expenses: Pfizer, Astra Zeneca Mavalynne Orozco Urdaneta Stock or Other Ownership: Celgene, Johnson and Johnson Armando Sardi Stock or Other Ownership: Celgene, Johnson and Johnson


2015 ◽  
Vol 55 (4) ◽  
pp. 449-454 ◽  
Author(s):  
Jan J. Jobsen ◽  
Job van der Palen ◽  
Mariël Brinkhuis ◽  
Francisca Ong ◽  
Henk Struikmans

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 21093-21093
Author(s):  
J. A. Shin ◽  
S. Gelber ◽  
J. Garber ◽  
R. Rosenberg ◽  
M. Przypyszny ◽  
...  

21093 Background: Young women with breast cancer have an increased risk of harboring a BRCA1/2 mutation. The frequency of genetic testing in this population is not well described. We evaluated the reported frequency and factors associated with genetic testing among young breast cancer survivors identified through the Young Survival Coalition (YSC), an international advocacy group for young women with breast cancer. Methods: Items regarding family history and genetic testing were included in a large web-based survey addressing quality of life and fertility issues for young women with breast cancer. All YSC members were invited by email in March 2003 (N= 1,703 women) to participate in this cross-sectional survey. Results: 657 women completed the on-line survey; 622 were eligible for this analysis (age <40, no metastatic or recurrent disease). Mean age at breast cancer diagnosis was 33 years; mean age when surveyed 35.5 years. Stages included: 0 (10%), I (27%), II (49%), III (12%), missing (3%). 90% of women were white; 64% married; 49% with children; 78% had at least a college education; 42% of women reported a 1st or 2nd degree relative with breast or ovarian cancer, and 13% considered themselves high-risk for harboring a genetic mutation at the time of diagnosis. At the time of the survey, 23% of women had undergone genetic testing, and 26% of those tested reported that a mutation was found. In a multivariate model, women who were younger (age 36–40 vs. age =30, O.R. 2.26, p=0.004), more educated (< college vs. > college education, O.R. 2.62, p=0.0009), had a family history of breast or ovarian cancer (O.R. 3.15, p<0.0001), and had had a mastectomy (O.R. 1.99, p=0.001) were more likely to have undergone genetic testing. Non-significant covariates included: age at survey, stage, time since diagnosis, race, marital status, employment, finances, insurance, number of children, comorbidities, baseline anxiety and depression, and fear of recurrence. Conclusion: The majority of women diagnosed with breast cancer age 40 and younger do not undergo genetic testing. Younger, more educated women with a family history of breast or ovarian cancer are more likely to get tested. Further research to define the appropriateness of genetic testing in this relatively high-risk population is warranted. No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document